[The role of delta-sleep-inducing peptide in the normalization of cardiac electric stability in experimental emotional stress].
Ul'ianinskiĭ. L S LS; Zviagintseva. M A MA; Arkhangel'skaia. M I MI
Key Findings
- 60 nm/kg of delta‑sleep‑inducing peptide normalized ventricular fibrillation thresholds in stressed rabbits.
- The peptide reduced or eliminated spontaneous ventricular premature beats during emotional stress.
- The effect was observed in an animal model, not yet tested in humans.
Practical Outcomes
- The peptide shows promise as a stress‑related anti‑arrhythmic agent, but because the data are limited to rabbits, there’s no clear protocol for human use. Biohackers should view this as early‑stage evidence and wait for safety, dosing, and human efficacy studies before considering experimentation.
Summary
In a rabbit study, a tiny dose (60 nmol per kg) of delta‑sleep‑inducing peptide helped keep the heart's electrical system stable during emotional stress, cutting down abnormal beats and raising the threshold for dangerous fibrillation.
Abstract
In chronic experiments on rabbits, a delta-sleeping inducing peptide was tested for effects on the cardiac electric stability and onset of ventricular premature beats during experimental emotional stress. The peptide in a dose of 60 nm/kg was found to normalize the thresholds of ventricular fibrillation and its predictors and to decrease or abolish spontaneous ventricular premature beats occurring during the stress. This suggests that the delta-sleep-inducing peptide may be used to prevent cardiac arrhythmias during stresses.
Study Information
pubmed
1990